Search

everythinglearnresearchcommunity

for

Search:↓

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Men with benign prostate hyperplasia have more meibomian gland loss and tear film problems.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

DHT in the human prostate is produced through multiple pathways, not just from testosterone.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Ursolic acid can shrink the prostate and lower a hormone linked to prostate growth in rats.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The normal human prostate does not significantly affect blood DHT levels.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Dutasteride may help shrink prostate cancer tumors.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Physical activity, height, and smoking affect prostate cancer risk.